FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma
Open Access
- 4 August 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (15) , 8675
Abstract
Oncogenic fusion genes have emerged as successful targets in several malignancies, such as chronic myeloid leukemia and lung cancer. Fusion of the fibroblast growth receptor 3 and the transforming acidic coiled coil containing protein—FGFR3-TACC3 fusion—is prevalent in 3–4% of human glioblastoma. The fusion protein leads to the constitutively activated kinase signaling of FGFR3 and thereby promotes cell proliferation and tumor progression. The subgroup of FGFR3-TACC3 fusion-positive glioblastomas presents with recurrent clinical and histomolecular characteristics, defining a distinctive subtype of IDH-wildtype glioblastoma. This review aims to provide an overview of the available literature on FGFR3-TACC3 fusions in glioblastoma and possible implications for actual clinical practice.Keywords
This publication has 99 references indexed in Scilit:
- The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastomaJournal of Clinical Investigation, 2013
- Oncogenic FGFR3 gene fusions in bladder cancerHuman Molecular Genetics, 2012
- The transcriptional landscape and mutational profile of lung adenocarcinomaGenome Research, 2012
- Transforming Fusions of FGFR and TACC Genes in Human GlioblastomaScience, 2012
- Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivoBritish Journal of Cancer, 2010
- Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cellsProceedings of the National Academy of Sciences, 2010
- ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 SplicingMolecular Cell, 2009
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Towards a Resolution of the Stoichiometry of the Fibroblast Growth Factor (FGF)–FGF Receptor–Heparin ComplexJournal of Molecular Biology, 2004